Loading...
Pathologic validation of an yttrium-90 trans-arterial radioembolization dosimetry: a case report
Yttrium-90 (Y-90) trans-arterial radioembolization (TARE) is used in the management of unresectable hepatocellular carcinoma (HCC). During the last 5 years, dosimetry software has been developed to allow for a more rigorous approach of dose prescription in Y-90 TARE. We present here a case study of...
Na minha lista:
| Udgivet i: | J Surg Case Rep |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Oxford University Press
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8088287/ https://ncbi.nlm.nih.gov/pubmed/33959251 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jscr/rjab078 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|